J3-9283 — Interim report
1.
Cell therapy for heart failure with preserved ejection fraction.

Invited lecture presenting the study design of the project

COBISS.SI-ID: 5208236
2.
Effects of CD34+ cell therapy in heart failure with preserved ejection fraction

Presentation of the study protocol at AHA Scientific Sessions and publication in a journal with the highest SCI IF in cardiology.

COBISS.SI-ID: 5414316
3.
Anti-arrhythmic potential of transendocardial CD34+ cell therapy in patients with chronic heart failure.

Presentation electrophysiologic effects of cell therapy at AHA Scientific Sessions and publication in a journal with the highest SCI IF in cardiology.

COBISS.SI-ID: 5414828